Fan Yu
- SEC CIK
- 0001668029
- Latest filing
- Aug 14, 2026
Holdings in Q3 2023
Holdings as of Sep 30, 2023, filed Nov 14, 2023. Long positions only; changes compare share counts with Q2 2023.
- Positions
- 5
- 0 vs. Q2 2023
- Portfolio value
- $1.41M
- +$134.9K (+10.6%) vs. Q2 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SGMTSagimet Biosciences Inc. | COM SER A | 57,190 | $503.3K | 35.7% | +57,190 | New | History |
| SONXSonendo, Inc. | COM | 547,945 | $408.7K | 29.0% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM | 20,592 | $347.8K | 24.7% | +16,110+359.5% | AddedConverted for a 1-for-25 split | History |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 69,303 | $137.9K | 9.8% | +69,303 | New | History |
| PREPrenetics Global Ltd | CLASS A ORD | 25,000 | $12.1K | 0.9% | 00.0% | Unchanged | History |
Sold out since Q2 2023 (2)
Positions held at the end of Q2 2023 that are gone from this filing.